Toxic epidermal necrolysis.
D000328:Adult; D000367:Age Factors; D002675:Child, Preschool; D004917:Erythromycin / Q000627:therapeutic use; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D009336:Necrosis; D010406:Penicillins / Q000627:therapeutic use; D010653:Phenylbutazone / Q000009:adverse effects; D011379:Prognosis; D012867:Skin / Q000473:pathology; D013203:Staphylococcal Infections / Q000188:drug therapy; D013262:Stevens-Johnson Syndrome / Q000139:chemically induced / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology / Q000276:immunology / Q000473:pathology / Q000628:therapy; D013449:Sulfonamides / Q000009:adverse effects; D013577:Syndrome
D010406:Penicillins; D013449:Sulfonamides; D004917:Erythromycin; D010653:Phenylbutazone